MeiraGTx Holdings (MGTX) Non-Current Deferred Tax Liability (2019 - 2023)
MeiraGTx Holdings (MGTX) reported Non-Current Deferred Tax Liability of $184000.0 for Q3 2023, up 7.6% on a YoY basis from $171000.0 in Q3 2022, and down 2.65% quarter-over-quarter from $189000.0 in Q2 2023.
MeiraGTx Holdings (MGTX) Non-Current Deferred Tax Liability (2019 - 2023) Analysis & Trends
MeiraGTx Holdings has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $184000.0 in Q3 2023.
- For the quarter ending Q3 2023, Non-Current Deferred Tax Liability rose 7.6% year-over-year to $184000.0; the trailing twelve-month figure through Sep 2023 stood at $184000.0 (up 7.6% YoY), and the FY2022 full-year result was $186000.0, down 5.1% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2023 stood at $184000.0, down from $189000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $214000.0 in Q4 2020, with the low at $171000.0 in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $193676.5 across 5 years, with a median of $194159.0 in 2020.
- Annual changes were most pronounced in 2020 — Non-Current Deferred Tax Liability increased 9.71% — and 2022, when it fell 14.93%.
- MeiraGTx Holdings' Non-Current Deferred Tax Liability stood at $195053.0 in 2019, then rose by 9.71% to $214000.0 in 2020, then fell by 8.41% to $196000.0 in 2021, then fell by 5.1% to $186000.0 in 2022, then dropped by 1.08% to $184000.0 in 2023.
- The last three Non-Current Deferred Tax Liability figures came in at $184000.0 (Q3 2023), $189000.0 (Q2 2023), and $189000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 184,000.00 |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 196,000.00 |
| Dec 31, 2021 | 196,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Jun 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 206,000.00 |